Interestingly, HIF2α immunostaining was also more intense in the nucleus of hepatocytes in NAFLD patients, which is in line with nuclear HIF2 expression upon Vhl inactivation in mouse liver shown in Figure 5B. This evidence concerns the gene EPAS1 and metabolic dysfunction-associated steatotic liver disease.